DECEMBER 20216December - 14 - 2021 volume 05 - Issue 25 (ISSN 2691-4093) Published by ValleyMedia, Inc. Managing EditorAlex D'souzaEditorial StaffVisualizerChris LynnSalesAndrew D'Souzaandrew.dsouza@medicaltechoutlook.comEmailsales@medicaltechoutlook.comeditor@medicaltechoutlook.commarketing@medicaltechoutlook.comJoshua Parker Merlin WatsonJoe Philip Laura PintoTo subscribe to MedicalTech OutlookVisit www.medicaltechoutlook.com Copyright © 2021 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffAlex D'souzaManaging Editoreditor@medicaltechoutlook.comIn the last two years, we all witnessed how modern technologies came to the aid of healthcare systems to overcome the challenges of the COVID-19 pandemic. Various evolving technologies were leveraged for streamlining patient care, to successfully provide remote services, and effectively manage patient vital signs, and come up with better diagnosis and treatment processes. The applications of these emerging technologies in this industry will continue been helping various professionals and institutions to expand their capabilities and deliver a much more accurate and effective treatment and care.Without any doubt, more exciting and outstanding innovations can be expected from an entirely technological driven healthcare industry. Nanotechnology is one such anticipated advancement. Nanoparticles will be used to target tumours, to improve medical imaging and also in drug delivery systems. Besides, nanoparticles will also be used for multi-functional treatments where they can be used to find tumours and also to carry drugs for treatment. Nanotechnology will also help to increase the speed of DNA sequencing, and thereby, provide scaffolding for tissue regeneration and wound treatment.At the same time, there will be a rapid increase in the adoption of IoMT devices in the following years. The widespread telehealth concept and the challenges from pandemic have led to the high demand for IoMT devices. These devices will largely help in bringing healthcare services to remote areas where full-time hospitals are not affordable. Portable point-of-care devices will be able to run any tests efficiently and can especially help patients with limited mobility.In this edition of MedTech Outlook, we bring you the story of some of the medtech companies that deliver the best outcomes for their clients. This edition also offers a combination of thought leadership articles from subject matter experts and exclusive insights from CIOs and CXOs. We hope this edition will provide you with the right assistance in choosing the best medtech company according to your requirements.Let us know your thoughts!The Dawn of Next-Generation Healthcare TechnologySarah FernandesEDITORIAL
< Page 5 | Page 7 >